Cellectis SA (CLLS)
1.88
+0.02
(+1.08%)
USD |
NASDAQ |
Nov 22, 16:00
1.88
0.00 (0.00%)
After-Hours: 16:49
Cellectis Total Liabilities (Quarterly): 266.45M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 266.45M |
| June 30, 2024 | 258.54M |
| March 31, 2024 | 263.89M |
| December 31, 2023 | 249.58M |
| September 30, 2023 | 133.58M |
| June 30, 2023 | 131.12M |
| March 31, 2023 | 130.92M |
| December 31, 2022 | 135.28M |
| September 30, 2022 | 133.97M |
| June 30, 2022 | 140.36M |
| March 31, 2022 | 144.14M |
| December 31, 2021 | 145.60M |
| September 30, 2021 | 150.74M |
| June 30, 2021 | 155.24M |
| March 31, 2021 | 152.97M |
| December 31, 2020 | 160.62M |
| September 30, 2020 | 158.75M |
| June 30, 2020 | 127.64M |
| March 31, 2020 | 100.55M |
| December 31, 2019 | 112.00M |
| September 30, 2019 | 98.70M |
| June 30, 2019 | 100.22M |
| March 31, 2019 | 79.63M |
| December 31, 2018 | 50.57M |
| September 30, 2018 | 48.48M |
| Date | Value |
|---|---|
| June 30, 2018 | 45.29M |
| March 31, 2018 | 47.31M |
| December 31, 2017 | 48.90M |
| September 30, 2017 | 49.26M |
| June 30, 2017 | 57.20M |
| March 31, 2017 | 54.49M |
| December 31, 2016 | 56.76M |
| September 30, 2016 | 66.32M |
| June 30, 2016 | 73.82M |
| March 31, 2016 | 77.87M |
| December 31, 2015 | 84.67M |
| September 30, 2015 | 70.39M |
| June 30, 2015 | 71.85M |
| March 31, 2015 | 367.94M |
| December 31, 2014 | 94.95M |
| June 30, 2014 | 31.38M |
| December 31, 2013 | 36.40M |
| June 30, 2013 | 34.70M |
| June 30, 2013 | 34.70M |
| December 31, 2012 | 31.77M |
| June 30, 2012 | 26.81M |
| June 30, 2012 | 26.81M |
| December 31, 2011 | 94.87M |
| December 31, 2010 | 18.96M |
| June 30, 2010 | 12.64M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
100.55M
Minimum
Mar 2020
266.45M
Maximum
Sep 2024
162.60M
Average
144.87M
Median
Total Liabilities (Quarterly) Benchmarks
| Edap TMS SA | 40.66M |
| DBV Technologies SA | 39.02M |
| Genfit SA | 117.09M |
| Adaptimmune Therapeutics PLC | 237.45M |
| Akari Therapeutics PLC | 9.428M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 395.88M |
| Shareholders Equity (Quarterly) | 129.42M |
| Debt to Equity Ratio | 0.3579 |
| Current Ratio | 1.777 |
| Net Debt Paydown Yield | -1.21% |